Delivery Order SPE2DB22D1106-SPE2DB25FETF7
Award Date
6/12/25
Potential Completion Date
6/13/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RABAVERT rabies vaccine with diluents. The contract, valued at $2,095.80, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of March 14, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,142.59 for the supply of RABAVERT Rabies Vaccine with diluents. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 15, 2024. The contract is not designated under any set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This federal contract award, valued at $1,737.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a critical medical product, with a completion date of January 28, 2025. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,479.00 firm fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of June 18, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $40,239.36, is a firm fixed price delivery order, and has an ultimate completion date of March 11, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,555.15, is for the delivery of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of March 19, 2025 and is a firm fixed-price delivery order. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,399.00 delivery order contract is for the provision of RABAVERT rabies vaccine with diluents. The contract has a firm fixed price pricing type and a completion date of July 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,479.00 firm-fixed-price delivery order is for the provision of RABAVERT RABIES VACC W-DILUENTS, with a completion date of June 10, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a rabies vaccine, with a ceiling value of $1,308.04 and a period of performance through June 24, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) to provide RABAVERT Rabies Vaccine with Diluents. The $46,385.15 firm fixed-price contract has an ultimate completion date of May 30, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen...